Literature DB >> 6815362

Probable clonal origin of neurofibrosarcoma in a patient with hereditary neurofibromatosis.

J M Friedman, P J Fialkow, C L Greene, M N Weinberg.   

Abstract

A neurofibroma, a fibroma, a primary neurofibrosarcoma, and four neurofibrosarcoma metastases from a woman with hereditary neurofibromatosis who was heterozygous (GdB/GdA-) for the X-linked enzyme glucose-6-phosphate dehydrogenase were studied to determine the number of cells from which the tumors developed. Both enzyme types were observed in the benign tumors in proportions similar to those present in seven different normal tissues studied. These findings indicated that the benign tumors arose from many cells. In marked contrast, only type A activity was detected in the primary neurofibrosarcoma and in all of the metastases. Two or more steps probably were involved in the development of neurofibrosarcoma in this patient: the inherited genetic mutation producing neurofibromatosis and a rare event or combination of events that permitted a single cell to undergo malignant proliferation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6815362

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  3 in total

1.  Polyclonal nature of diffuse proliferation of interstitial cells of Cajal in patients with familial and multiple gastrointestinal stromal tumours.

Authors:  H Chen; S Hirota; K Isozaki; H Sun; A Ohashi; K Kinoshita; P O'Brien; L Kapusta; I Dardick; T Obayashi; T Okazaki; Y Shinomura; Y Matsuzawa; Y Kitamura
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

2.  Cerebral cavernous malformations: somatic mutations in vascular endothelial cells.

Authors:  Judith Gault; Issam A Awad; Peter Recksiek; Robert Shenkar; Robert Breeze; Michael Handler; Bette K Kleinschmidt-DeMasters
Journal:  Neurosurgery       Date:  2009-07       Impact factor: 4.654

Review 3.  Multicolor lineage tracing methods and intestinal tumors.

Authors:  Hirotsugu Yanai; Toshihiro Tanaka; Hiroo Ueno
Journal:  J Gastroenterol       Date:  2013-01-11       Impact factor: 7.527

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.